Tablet Coatings Market Forecasts to 2030 - Global Analysis By Polymer Type (Cellulosic Polymers, Vinyl Derivatives & Other Polymer Types), By Type (Enteric-coated Tablets, Film-coated Tablets & Other Types), Functionality, End User & By Geography

According to Stratistics MRC, the Global Tablet Coatings Market is accounted for $920.6 million in 2023 and is expected to reach $1537.3 million by 2030 growing at a CAGR of 7.6% during the forecast period. Tablet coatings are thin layers of polymers or compounds on pharmaceutical tablets. These coatings serve multiple purposes, such as improving appearance, taste-masking, protecting against moisture or light degradation, facilitating swallowing, controlling drug release, and enhancing stability. They play a vital role in ensuring effective drug delivery, optimizing patient compliance and preserving the integrity of active pharmaceutical ingredients within oral dosage forms.

According to the European Federation of Pharmaceutical Industries and Associations, 2022 report, the production of pharmaceuticals in Europe was valued at EUR 286,697 million (USD 30,7416.88) in 2020 and EUR 300,000 million (USD 321681.30) in 2021.

Market Dynamics:

Driver:

Rapid expansion of the pharmaceutical sector

The rapid expansion of the pharmaceutical sector acts as a significant driver in the tablet coatings market. The pharmaceutical industry's growth, fueled by evolving healthcare needs and a surge in chronic diseases, propels the demand for advanced drug formulations. Tablet coatings play a pivotal role in enhancing drug efficacy, patient compliance and product differentiation. Moreover, as pharmaceutical companies strive for innovative drug delivery systems, coatings enable modified-release formulations, driving the adoption of coated tablets. This expansion creates opportunities for improved formulations, driving the growth of the tablet coatings market.

Restraint:

Time-consuming and costly drug development procedures

The lengthy development cycles and extensive research involved in creating new formulations or modifying existing coatings amplify costs and hinder rapid market entry. Delays in formulation approvals and stringent testing processes further extend the timeline, impacting product launches. These exhaustive procedures not only inflate development expenses but also impede the agility needed for timely responses to market demands. This restraint limits innovation and may deter smaller players from entering the market, affecting overall industry growth.

Opportunity:

Escalating investment in research and development

The escalating investment in research and development presents a compelling opportunity in the tablet coatings market. Increased R&D investments drive innovation, fostering the development of advanced coating materials and technologies. This surge in research leads to novel formulations that improve drug delivery, offer enhanced stability, and cater to specific patient needs. Moreover, it enables the creation of eco-friendly and sustainable coatings, aligning with the growing demand for environmentally conscious pharmaceutical products. This investment surge not only fosters market expansion but also promotes the evolution of tablet coatings towards more efficient and tailored solutions.

Threat:

Stringent regulatory frameworks

Compliance with complex and evolving regulations adds significant challenges to product development, approvals and market entry. Meeting stringent quality standards, documentation requirements and safety evaluations demands substantial resources and time increasing development costs. Moreover, changes in regulations can impact existing products, necessitating adaptations. These hurdles hinder innovation, limit market entry for smaller firms and potentially delay the introduction of advanced coatings, posing a threat by impeding growth and competitiveness within the tablet coatings industry.

COVID-19 Impact:

The COVID-19 pandemic has influenced the tablet coatings market by disrupting supply chains and impacting production schedules. Increased demand for pharmaceuticals has driven the market, but challenges like logistical issues and workforce limitations have affected operations. Furthermore, delays in clinical trials and regulatory processes have impacted the introduction of new coatings. The industry has adapted through digital technologies, emphasizing remote work and implementing safety measures, but the overall impact underscores the sector's resilience and adaptability.

The cellulose polymers segment is expected to be the largest during the forecast period

Over the forecast period, the cellulose polymers segment is expected to dominate the tablet coatings market due to their versatile properties. Cellulose derivatives like hydroxypropyl methylcellulose (HPMC) and ethyl cellulose offer excellent film-forming abilities, controlled-release properties and stability enhancement for pharmaceutical formulations. Their biocompatibility, safety, and suitability for various drug types contribute to their widespread adoption. Additionally, the growing demand for natural and plant-based coatings aligns with cellulose polymers' appeal, positioning them as favored choices for tablet coatings, thus driving their anticipated dominance in the market.

The film-coated tablets segment is expected to have the highest CAGR during the forecast period

During the forecast period, the film-coated tablets segment is poised to witness significant growth. Film coatings enhance the aesthetic appeal of tablets, mask unpleasant tastes and protect against environmental factors, contributing to improved patient compliance. Moreover, they enable controlled-release formulations, ensuring precise drug delivery. Additionally, the rising demand for patient-friendly dosage forms and the ability of film coatings to accommodate various drug formulations align with current pharmaceutical trends, fostering the growth of this segment in the tablet coatings market.

Region with largest share:

North America is expected to dominate the tablet coatings market due to its robust pharmaceutical infrastructure, extensive R&D investments and strong emphasis on innovative drug formulations. Favorable regulatory frameworks and substantial healthcare expenditures further drive market growth. Additionally, the region's increasing demand for modified-release formulations, coupled with a high prevalence of chronic diseases, fuels the adoption of advanced tablet coatings.

Region with highest CAGR:

Asia Pacific is poised to register lucrative growth in the tablet coatings market owing to the region's expanding pharmaceutical sector, rising healthcare expenditures, and increasing investments in R&D, which foster market opportunities. Additionally, a growing population, changing lifestyles and a surge in chronic diseases drive demand for pharmaceuticals, stimulating the need for advanced tablet coatings. Furthermore, the presence of a large pool of contract manufacturing organizations (CMOs) and improving healthcare infrastructure contribute to the region's attractiveness, fueling the projected robust growth of tablet coatings in Asia Pacific.

Key players in the market:

Some of the key players in tablet coatings market include Ashland Global Holdings Inc., BASF SE, Clariant AG, Coating Place, Inc., Colorcon, DOW Inc., DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., Ideal Cures Pvt. Ltd., JRS Pharma, Kerry Group, Merck KGaA, PPG Industries, Inc., Roquette Freres, Sensient Technologies Corporation and Shin-Etsu Chemical Co., Ltd.

Key Developments:

In March 2023, Colorcon announced the launch of its new Soluplus® Encapsulation Technology. This technology is designed to improve the solubility and bioavailability of poorly water-soluble drugs.

In February 2023, Sensient Technologies announced the expansion of its tablet coating capabilities in the US. The company is investing $10 million in the expansion, which is expected to be completed by the end of 2023. The expansion will increase the company's tablet coating capacity by 50%.

In February 2022, JRS PHARMA introduced the solution for Titanium Dioxide free ready-to-use coatings, VIVACOAT® free.

Polymer Types Covered:

• Cellulosic Polymers
• Vinyl Derivatives
• Acrylic Polymers
• Other Polymer Types

Types Covered:

• Enteric-coated Tablets
• Film-coated Tablets
• Gelatin-coated Tablets
• Sugar-coated Tablets
• Other Types

Functionalities Covered:

• Non-functional Non-modifying Coatings
• Functional Modifying Coatings
• Functional Non-modifying Coatings

End Users Covered:

• Pharmaceutical Industry
• Nutraceutical Industry
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances